EMBL invites researchers, entrepreneurs, investors as well as members of its own community – including alumni and staff – to Dundee, the City of Discovery, for EMBL in the UK 2022. This year, hear how research discoveries can effectively be translated into impact. What lessons can we learn from previous ventures in order to maximise future collaborations?
Professor Jenny Woof has been named as one of this year’s winners of the Chancellor’s Award for Outstanding Contributions to Teaching.
Professor Woof commented “I am delighted and honoured to receive this award. I’m very aware that delivery of an excellent programme of teaching can only be achieved through strong teamwork, and I am very fortunate to work with colleagues across the Schools of Life Sciences and Medicine who are so committed to delivery of a first-rate student experience.”
Professor Alessio Ciulli has been awarded a European Federation for Medicinal Chemistry and Chemical Biology Awards 2022. He has been named the winner of the 2022 Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery. This award has been in recognition of his “pioneering work in the field of proteolysis-targeting chimera (PROTAC) technology for drug-induced targeted protein degradation.
Abstract:
The results of the 2021 Research Excellence Framework (REF) were announced today. Dundee is the top-ranking University for Biological Sciences research, a position we have maintained since the last REF exercise in 2014. The REF2021 assessment has scored SLS as having a total of 71% of its activities being ‘world leading’ (4*) and 28% of its activities being ‘internationally excellent’ (3*).
Professor Kate Storey, of the University of Dundee, has been elected a Fellow of the Royal Society (FRS), the world's oldest scientific academy in continuous existence.
Professor Storey is Head of the Division of Cell & Developmental Biology and Chair of Neural Development in the School of Life Sciences at Dundee.
Professor Storey said, “Being made a Fellow of the Royal Society is a major honour for any scientist and I am delighted to join the illustrious list of Fellows.
A team from the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee has developed a new parasite gene-editing technology. This method, known as oligo-targeting, involves delivering short DNA fragments to parasites using a pulse of electricity. The DNA, including the desired edits, is then incorporated into the genomes of cells that are in the process of replicating their DNA. The approach is fast, simple, precise, and inexpensive.
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
As part of separate partnerships, Amphista will collaborate with Merck Healthcare and Bristol Myers Squibb to leverage the company’s targeted protein degradation (TPD) technology and generate therapeutics in multiple disease areas.
